{
    "title": "Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.",
    "abst": "Second- and third-generation cephalosporins, especially cefotetan, are increasingly associated with severe, sometimes fatal immune hemolytic anemia. We noticed that 10 of our 35 cases of cefotetan-induced hemolytic anemias were in patients who had received cefotetan prophylactically for obstetric and gynecologic procedures. Eight of these cases of severe immune hemolytic anemia are described.",
    "title_plus_abst": "Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Second- and third-generation cephalosporins, especially cefotetan, are increasingly associated with severe, sometimes fatal immune hemolytic anemia. We noticed that 10 of our 35 cases of cefotetan-induced hemolytic anemias were in patients who had received cefotetan prophylactically for obstetric and gynecologic procedures. Eight of these cases of severe immune hemolytic anemia are described.",
    "pubmed_id": "10411803",
    "entities": [
        [
            14,
            30,
            "hemolytic anemia",
            "Disease",
            "D000743"
        ],
        [
            67,
            76,
            "cefotetan",
            "Chemical",
            "D015313"
        ],
        [
            147,
            161,
            "cephalosporins",
            "Chemical",
            "D002511"
        ],
        [
            174,
            183,
            "cefotetan",
            "Chemical",
            "D015313"
        ],
        [
            249,
            265,
            "hemolytic anemia",
            "Disease",
            "D000743"
        ],
        [
            305,
            314,
            "cefotetan",
            "Chemical",
            "D015313"
        ],
        [
            323,
            340,
            "hemolytic anemias",
            "Disease",
            "D000743"
        ],
        [
            375,
            384,
            "cefotetan",
            "Chemical",
            "D015313"
        ],
        [
            482,
            498,
            "hemolytic anemia",
            "Disease",
            "D000743"
        ]
    ],
    "split_sentence": [
        "Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.",
        "Second- and third-generation cephalosporins, especially cefotetan, are increasingly associated with severe, sometimes fatal immune hemolytic anemia.",
        "We noticed that 10 of our 35 cases of cefotetan-induced hemolytic anemias were in patients who had received cefotetan prophylactically for obstetric and gynecologic procedures.",
        "Eight of these cases of severe immune hemolytic anemia are described."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "D000743\tDisease\themolytic anemia\tSevere immune <target> hemolytic anemia </target> associated with prophylactic use of cefotetan in obstetric and gynecologic procedures .",
        "D015313\tChemical\tcefotetan\tSevere immune hemolytic anemia associated with prophylactic use of <target> cefotetan </target> in obstetric and gynecologic procedures .",
        "D002511\tChemical\tcephalosporins\tSecond- and third-generation <target> cephalosporins </target> , especially cefotetan , are increasingly associated with severe , sometimes fatal immune hemolytic anemia .",
        "D015313\tChemical\tcefotetan\tSecond- and third-generation cephalosporins , especially <target> cefotetan </target> , are increasingly associated with severe , sometimes fatal immune hemolytic anemia .",
        "D000743\tDisease\themolytic anemia\tSecond- and third-generation cephalosporins , especially cefotetan , are increasingly associated with severe , sometimes fatal immune <target> hemolytic anemia </target> .",
        "D015313\tChemical\tcefotetan\tWe noticed that 10 of our 35 cases of <target> cefotetan </target> -induced hemolytic anemias were in patients who had received cefotetan prophylactically for obstetric and gynecologic procedures .",
        "D000743\tDisease\themolytic anemias\tWe noticed that 10 of our 35 cases of cefotetan-induced <target> hemolytic anemias </target> were in patients who had received cefotetan prophylactically for obstetric and gynecologic procedures .",
        "D015313\tChemical\tcefotetan\tWe noticed that 10 of our 35 cases of cefotetan-induced hemolytic anemias were in patients who had received <target> cefotetan </target> prophylactically for obstetric and gynecologic procedures .",
        "D000743\tDisease\themolytic anemia\tEight of these cases of severe immune <target> hemolytic anemia </target> are described ."
    ],
    "lines_lemma": [
        "D000743\tDisease\themolytic anemia\tsevere immune <target> hemolytic anemia </target> associate with prophylactic use of cefotetan in obstetric and gynecologic procedure .",
        "D015313\tChemical\tcefotetan\tsevere immune hemolytic anemia associate with prophylactic use of <target> cefotetan </target> in obstetric and gynecologic procedure .",
        "D002511\tChemical\tcephalosporins\tsecond- and third-generation <target> cephalosporin </target> , especially cefotetan , be increasingly associate with severe , sometimes fatal immune hemolytic anemia .",
        "D015313\tChemical\tcefotetan\tsecond- and third-generation cephalosporin , especially <target> cefotetan </target> , be increasingly associate with severe , sometimes fatal immune hemolytic anemia .",
        "D000743\tDisease\themolytic anemia\tsecond- and third-generation cephalosporin , especially cefotetan , be increasingly associate with severe , sometimes fatal immune <target> hemolytic anemia </target> .",
        "D015313\tChemical\tcefotetan\twe notice that 10 of our 35 case of <target> cefotetan </target> -induced hemolytic anemia be in patient who have receive cefotetan prophylactically for obstetric and gynecologic procedure .",
        "D000743\tDisease\themolytic anemias\twe notice that 10 of our 35 case of cefotetan-induced <target> hemolytic anemia </target> be in patient who have receive cefotetan prophylactically for obstetric and gynecologic procedure .",
        "D015313\tChemical\tcefotetan\twe notice that 10 of our 35 case of cefotetan-induced hemolytic anemia be in patient who have receive <target> cefotetan </target> prophylactically for obstetric and gynecologic procedure .",
        "D000743\tDisease\themolytic anemia\teight of these case of severe immune <target> hemolytic anemia </target> be describe ."
    ]
}